期刊文献+

HBcAg DNA疫苗诱导小鼠(H—2^b)特异性细胞和体液免疫应答 被引量:7

Specific cellular and humoral immune responses in H 2 b mice induced by DNA immunization of HBV core gene
原文传递
导出
摘要 目的观察HBcAgDNA疫苗(pJW4303/HBc)免疫C57BL/6小鼠(H2b)的特异性细胞和体液免疫应答。方法基因枪和肌肉注射两种方法接种DNA疫苗;ELISA法检测小鼠血清抗HBc(IgG)及IgG亚类(IgG1,IgG2a);51铬释放法检测小鼠脾细胞HBcAg特异性CTL活性。结果该DNA疫苗体外可表达HBcAg;小鼠经基因枪或肌肉注射接种该疫苗后血清抗HBc滴度分别达1∶328050和1∶109350;肌肉注射组抗HBc亚类以IgG2a为主;两种方法接种小鼠的特异性CTL杀伤率分别达53.1%和52.8%。结论HBcAgDNA疫苗在H2b小鼠实验中表现出良好的细胞免疫和体液免疫原性。 Objective To observe the specific cellular and humoral immune responses in H 2 b mice after DNA immunization of HBV core gene.Methods The DNA vaccine(pJW4303/HBc) was constructed by inserting HBV core gene fragment into the reading frame of plasmid pJW4303.The immunization was performed by gene gun and intramuscular injection in this experiment.Anti HBc(IgG)and its subtypes(IgG1,IgG2a)in mice sera were detected by ELISA.HBcAg specific cytotoxic T lymphocyte (CTL) activity was measured by 51 Chromium release assay.Results The expression of HBcAg was demonstrated by ELISA and Western blot in 293T cells transfected with pJW4303/HBc.The end point titers of serum anti HBc in immunized mice were 1∶328 050 (gene gun method) and 1∶109 350 (intramuscular method).In both groups of gene gun and intramuscular immunization,IgG2a level was sightly higher than that of IgG1.HBcAg specific CTL activities were 53.1% in gene gun group and 52.85%in intramuscular group.ConclusionThe results showed that the DNA vaccine of pJW4303/HBc had strong antigenecity in both cellular and humoral immunity.
出处 《中华传染病杂志》 CAS CSCD 北大核心 1999年第2期104-107,共4页 Chinese Journal of Infectious Diseases
基金 卫生部科学研究基金
关键词 乙型肝炎 核心抗原 DNA序列 细胞免疫 Hepatitis B core antigen DNA vaccine Mice
  • 相关文献

参考文献3

  • 1叶廷安 詹美云.通过乙型肝炎病毒核心基因5'端的修饰使核心抗原在大肠杆菌中高效表达[J].病毒学报,1988,4:312-318.
  • 2Yasutomi Y,J Virol,1996年,70卷,678页
  • 3叶廷安,病毒学报,1988年,4卷,312页

共引文献3

同被引文献32

  • 1Encke J,Intervirology,1999年,42卷,2/3期,117页
  • 2Chen P J, Chen D S. Hepatitis B virus infection and hepatocellular carci noma:molecular genetics and clinical perspectives[J]. Semn Liver Dis, 1999; 19(3) :253
  • 3Musacchio A, Rodriguez F G, Herrera A M et al. Multivalent DNA-based immunization against hepatitis B virus with plasmids encoding surface and core antigens[J]. Biophys Res Commun ,2001 ;282(2) :442
  • 4Geissler M, Tokushige K, Chante C C et al. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization[J]. Gastroenterology, 1997; 112(4): 1307
  • 5Koziel M J.The immunopathogenesis of HBV infection[J].Antivir Ther, 1998; 3(suppl. 13): 13
  • 6McCluskie M J, Brazolot Millian C L, Gramzinski R A et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates[J] .Mol Med, 1999;5(5) :287
  • 7Davis H L, Millan C L B, Mancini M et al. DNA-based immunization against hepatitis B virus antigen H(HBsAg) in normal and HBaAg-trans- genic mice[J]. Vaccine, 1997; 15(8) :849
  • 8Bertoleiti A, Delios M M, Boni C et al. Different cytokine proftles of in trahepatic T cell in chronic hepatitis B and hepatitis C virus infections[ J ]. Gastroenterology, 1997; 112( 1 ): 193
  • 9Milich D R. Immune response to the hepatitis: infection, animal models, vaccination[J]. Viral Hepat Rev, 1997;3(1):63
  • 10Schirmbeck R, Wild J, Stober D et al. Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen[J] .J Immunol, ,2000; 164(8) :4235

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部